Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.15 USD | +2.88% |
|
+9.62% | -31.26% |
06-28 | Sector Update: Health Care Stocks Edge Higher in Afternoon Trading | MT |
06-28 | Mizuho Securities Cuts Price Target on Apellis Pharmaceuticals to $49 From $52, Maintains Neutral Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.26% | 4.99B | |
+7.46% | 100B | |
+8.42% | 42.34B | |
-13.04% | 32.76B | |
+80.48% | 29.46B | |
-10.92% | 16.31B | |
+1.93% | 14.39B | |
-6.77% | 12.23B | |
+177.16% | 10.47B | |
+1.27% | 8.97B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Transcript : Apellis Pharmaceuticals, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 08